Skip to main content
Erschienen in: Virchows Archiv 4/2007

01.04.2007 | Original Article

Cytological diagnosis of malignant mesothelioma—improvement by additional analysis of hyaluronic acid in pleural effusions

verfasst von: L. Welker, M. Müller, O. Holz, E. Vollmer, H. Magnussen, R. A. Jörres

Erschienen in: Virchows Archiv | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

Cytology allows the diagnosis of malignant mesothelioma (MM) from effusions with high specificity but low sensitivity. Conversely, elevated levels of hyaluronic acid (HA) in effusions are sensitive indicators of MM, although specificity is insufficient. We studied whether the cytological diagnosis of MM could be improved by HA analysis. HA was analysed in patients with histologically confirmed MM (n = 162), adenocarcinoma or other malignant tumours (n = 100) and in 90 patients with benign pleural diseases. In 77 out of 162 effusions, all, and in 33 some, cytological criteria of MM were satisfied. The cut-off value of HA showing maximum diagnostic reliability (86%) regarding MM was 30 mg/l (sensitivity 87%, specificity 86%). A HA value of 100 mg/l yielded 39 and 98%, respectively. Seventy three out of 77 patients with cytological findings indicative of MM showed HA levels greater than 30 mg/l as well as 27 of 33 patients with suspicious lesions. These 100 patients were correctly recognised as having MM. The addition of HA analysis to cytology, requiring all or some criteria of MM as positive, increased sensitivity for MM from 48 to 71–91%, whereas specificity only slightly decreased to 94–96%. We conclude that the combined cytological and HA analysis of pleural effusions had the potential to improve the diagnosis of MM.
Literatur
1.
Zurück zum Zitat Achatzy R, Beba W, Ritschler R, Worn H, Wahlers B, Macha HN, Morgan JA (1989) The diagnosis, therapy and prognosis of diffuse malignant mesothelioma. Eur J Cardiothorac Surg 3:445–447PubMedCrossRef Achatzy R, Beba W, Ritschler R, Worn H, Wahlers B, Macha HN, Morgan JA (1989) The diagnosis, therapy and prognosis of diffuse malignant mesothelioma. Eur J Cardiothorac Surg 3:445–447PubMedCrossRef
2.
Zurück zum Zitat Antman K, Shemin R, Ryan L, Klegar K, Osteen R, Herman T, Lederman G, Corson J (1988) Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana–Farber Cancer Institute and Brigham and Women’s Hospital experience over two decades, 1965–1985. J Clin Oncol 6:147–153PubMed Antman K, Shemin R, Ryan L, Klegar K, Osteen R, Herman T, Lederman G, Corson J (1988) Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana–Farber Cancer Institute and Brigham and Women’s Hospital experience over two decades, 1965–1985. J Clin Oncol 6:147–153PubMed
3.
4.
Zurück zum Zitat Atagi S, Ogawara M, Kawahara M, Sakatani M, Furuse K, Ueda E, Yamamoto S (1997) Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma. Jpn J Clin Oncol 27:293–297PubMedCrossRef Atagi S, Ogawara M, Kawahara M, Sakatani M, Furuse K, Ueda E, Yamamoto S (1997) Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma. Jpn J Clin Oncol 27:293–297PubMedCrossRef
5.
Zurück zum Zitat Dahl IM, Solheim OP, Erikstein B, Müller E (1989) A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Hyaluronan as an indicator of progressive disease. Cancer 64:68–73PubMedCrossRef Dahl IM, Solheim OP, Erikstein B, Müller E (1989) A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Hyaluronan as an indicator of progressive disease. Cancer 64:68–73PubMedCrossRef
6.
Zurück zum Zitat Friman C, Hellström PE, Juvani M, Riska H (1977) Acid glycosaminoglycans (mucopolysaccharides) in the differential diagnosis of pleural effusion. Clin Chim Acta 76:357–361PubMedCrossRef Friman C, Hellström PE, Juvani M, Riska H (1977) Acid glycosaminoglycans (mucopolysaccharides) in the differential diagnosis of pleural effusion. Clin Chim Acta 76:357–361PubMedCrossRef
7.
Zurück zum Zitat Fuhrman C, Duche JC, Chouaid C, Abd Alsamad I, Atassi K, Monnet I, Tillement JP, Housset B (2000) Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies. Clin Biochem 33:405–410PubMedCrossRef Fuhrman C, Duche JC, Chouaid C, Abd Alsamad I, Atassi K, Monnet I, Tillement JP, Housset B (2000) Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies. Clin Biochem 33:405–410PubMedCrossRef
8.
Zurück zum Zitat Hillerdal G, Lindqvist U, Engström-Laurent A (1991) Hyaluronan in pleural effusions and in serum. Cancer 67:2410–2414PubMedCrossRef Hillerdal G, Lindqvist U, Engström-Laurent A (1991) Hyaluronan in pleural effusions and in serum. Cancer 67:2410–2414PubMedCrossRef
9.
Zurück zum Zitat Martensson G (1990) Diagnosing malignant pleural mesothelioma. Eur Respir J 3:985–986PubMed Martensson G (1990) Diagnosing malignant pleural mesothelioma. Eur Respir J 3:985–986PubMed
10.
Zurück zum Zitat Martensson G, Thylen A, Lindquist U, Hjerpe A (1994) The sensitivity of hyaluronan analysis of pleural fluid from patients with malignant mesothelioma and a comparison of different methods. Cancer 73:1406–1410PubMedCrossRef Martensson G, Thylen A, Lindquist U, Hjerpe A (1994) The sensitivity of hyaluronan analysis of pleural fluid from patients with malignant mesothelioma and a comparison of different methods. Cancer 73:1406–1410PubMedCrossRef
11.
Zurück zum Zitat Matzel W (1985) Biochemical and cytological features of diffuse mesotheliomas of the pleura. Arch Geschwulstforsch 55:259–64PubMed Matzel W (1985) Biochemical and cytological features of diffuse mesotheliomas of the pleura. Arch Geschwulstforsch 55:259–64PubMed
12.
Zurück zum Zitat Meyer K, Chaffee E (1939) Hyaluronic acid in pleural fluid associated with malignant tumour involving pleura and peritoneum. Pro Soc Exp Biol Med 42:797–800 Meyer K, Chaffee E (1939) Hyaluronic acid in pleural fluid associated with malignant tumour involving pleura and peritoneum. Pro Soc Exp Biol Med 42:797–800
13.
Zurück zum Zitat Parker C, Neville E (2003) Lung cancer * 8: management of malignant mesothelioma 1. Thorax 58:809–813PubMedCrossRef Parker C, Neville E (2003) Lung cancer * 8: management of malignant mesothelioma 1. Thorax 58:809–813PubMedCrossRef
14.
Zurück zum Zitat Peto J, Decarli A, La Vecchia C, Levi F, Negri E (1999) The European mesothelioma epidemic. Br J Cancer 79:666–672PubMedCrossRef Peto J, Decarli A, La Vecchia C, Levi F, Negri E (1999) The European mesothelioma epidemic. Br J Cancer 79:666–672PubMedCrossRef
15.
Zurück zum Zitat Pettersson T, Froseth B, Riska H, Klockars M (1988) Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. Chest 94:1037–1039PubMed Pettersson T, Froseth B, Riska H, Klockars M (1988) Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. Chest 94:1037–1039PubMed
16.
Zurück zum Zitat Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES (1997) The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 111:106–109PubMed Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES (1997) The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 111:106–109PubMed
17.
Zurück zum Zitat Spriggs AI, Boddington MM (1994) Atlas of serous fluid cytopathology. A guide to the cells of pleural, pericardial, peritoneal and hydrocele fluid. In: Gresham GA (ed) Current histopathology series, vol 14. Kluwer, Dordrecht (1989) Spriggs AI, Boddington MM (1994) Atlas of serous fluid cytopathology. A guide to the cells of pleural, pericardial, peritoneal and hydrocele fluid. In: Gresham GA (ed) Current histopathology series, vol 14. Kluwer, Dordrecht (1989)
18.
Zurück zum Zitat Stevens MW, Leong AS, Fazzalari NL, Dowling KD, Henderson DW (1992) Cytopathology of malignant mesothelioma: a stepwise logistic regression analysis. Diagn Cytopathol 8:333–341PubMedCrossRef Stevens MW, Leong AS, Fazzalari NL, Dowling KD, Henderson DW (1992) Cytopathology of malignant mesothelioma: a stepwise logistic regression analysis. Diagn Cytopathol 8:333–341PubMedCrossRef
19.
Zurück zum Zitat Thylen A, Hjerpe A, Martensson G (2001) Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma. Cancer 92:1224–1230PubMedCrossRef Thylen A, Hjerpe A, Martensson G (2001) Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma. Cancer 92:1224–1230PubMedCrossRef
20.
Zurück zum Zitat Welker L, Jörres RA, Costabel U, Magnussen H (2004) Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 24:1000–1006PubMedCrossRef Welker L, Jörres RA, Costabel U, Magnussen H (2004) Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 24:1000–1006PubMedCrossRef
Metadaten
Titel
Cytological diagnosis of malignant mesothelioma—improvement by additional analysis of hyaluronic acid in pleural effusions
verfasst von
L. Welker
M. Müller
O. Holz
E. Vollmer
H. Magnussen
R. A. Jörres
Publikationsdatum
01.04.2007
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 4/2007
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-007-0375-x

Weitere Artikel der Ausgabe 4/2007

Virchows Archiv 4/2007 Zur Ausgabe

Announcements

Announcements

Neu im Fachgebiet Pathologie

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Molekularpathologische Untersuchungen im Wandel der Zeit

11.04.2024 | Pathologie | Schwerpunkt: Next Generation Pathology

Vergleichende Pathologie in der onkologischen Forschung

Open Access 08.04.2024 | GIST | CME

Gastrointestinale Stromatumoren

Wo stehen wir?

03.04.2024 | Zielgerichtete Therapie | Schwerpunkt: Next Generation Pathology

Personalisierte Medizin in der Onkologie